Table 4.
Sample source | Senegalese IE studya (n=55) |
Senegalese H2A studya (n=55) |
US clinicalb (n=52) |
---|---|---|---|
The status of ARV | ARV-naïve | ARV-experienced | ARV-naïve & experienced |
Year samples collected CD4 cells | 2004–2006 | 2010–2011 | 2011–2012 |
Mean cells/mm3 | 605 | 338 | N/A |
No. (%) with counts of: | |||
>500 | 30(55) | 7(13) | |
350–500 | 9(16) | 13(24) | |
<350 | 16(29) | 35(64) | |
HIV-2 plasma VL | |||
Mean log10 copies/mL | 2.66 | 3.11 | 3.03 |
No. (%) with VL of: | |||
Not detected | 20(36) | 26(47) | 21(40) |
Detected, <10 copies/mL | 5(9) | 2(4) | 2(4) |
Quantifiable range, >10 copies/mL | 30(55) | 27(49) | 29(56) |
Median log10 copies/mL (range) | 1.69(1.00–3.75) | 2.45(1.20–4.23) | 2.86(1.23–4.20) |
Single sample per individual patient.
Patients’ clinical information was limited.